AccurKardia
PrivateLast Round
Seed
Jun 20, 2023
Total Funding Raised
$2.7M
Company Overview
AccurKardia is a medical software company that provides an automated, clinical-grade electrocardiogram (ECG) interpretation software platform for cardiac monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Medical Devices
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AccurKardia Comparables
Compare AccurKardia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cardiomatics | 92% | |
| Idoven | 86% | |
| Powerful Medical | 84% | |
AccurKardia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 20, 2023 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 52% MoM, reaching 1.2K.
- Jan 8, 2026
AccurECG 2.0 launched after receiving FDA 510(k) clearance.
AccurKardia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AccurKardia's valuation, stock price, and market status.